R. Sanders Williams
Director, Bristol-Myers Squibb.
Companies
- Tenaya Therapeutics, Inc.Board member Jul 29, 2021 to now1
- LabCorpBoard member May 18, 2007 to Feb 8, 20242
- AmgenBoard member Oct 20, 2014 to May 23, 20233
- Bristol-Myers SquibbBoard member Sep 19, 2006 to Feb 5, 20134
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Amgen AMGN6,240 shares5$2.7M at $437.78May 19, 2023
LabCorp LH8,120 shares6$2.6M at $323.23Feb 7, 2024
Bristol-Myers Squibb BMY500 shares7$30.5K at $60.95Sep 19, 2006
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 7, 2024Exercised options 947 shares of LabCorp6
- May 19, 2023Granted 939 shares of Amgen5
- Feb 11, 2023Exercised options 742 shares of LabCorp8
- Aug 22, 2022Sold 200 shares at $249.96 of Amgen9
- May 23, 2022Sold 600 shares at $250.00 of Amgen10
- May 17, 2022Granted 855 shares of Amgen11
- Mar 25, 2022Sold 572 shares at $272.98 of LabCorp12
- Feb 2, 2022Exercised options 771 shares of LabCorp13
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARLabCorp, Board member
- 3SEC EDGARAmgen, Board member
- 4SEC EDGARBristol-Myers Squibb, Board member
- 5
- 6
- 7
- 8SEC EDGARForm 4 filed Feb 14, 2023
- 9SEC EDGARForm 4 filed Aug 22, 2022
- 10SEC EDGARForm 4 filed May 23, 2022
- 11SEC EDGARForm 4 filed May 19, 2022
- 12SEC EDGARForm 4 filed Mar 29, 2022
- 13SEC EDGARForm 4 filed Feb 4, 2022